Search - tctmd.com

Displaying 1 - 20 of 102

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

Todd Neale

June 20, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Shelley Wood

July 18, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

RAISE: Reteplase May Be Another Option for Stroke Thrombolysis

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Less Is More: Lp(a) Much More Atherogenic Than LDL

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content